Melanin is no longer best understood as a passive UV filter. It is emerging as a programmable, redox-active pigment system that converts environmental energy and oxidative stress into lasting genomic and immunological consequences, placing pigment metabolism at the center of melanoma biology.
Recent Advances:
Oxidative melanogenesis activates nitric-oxide synthase (NOS), generating reactive nitrogen species that oxidize melanin fragments into electronically excited triplet carbonyls. These intermediates drive delayed cyclobutane pyrimidine dimers (dCPDs) hours after ultraviolet exposure, establishing a pigment-powered window of “dark mutagenesis.” In melanoma, this pigment-NOS-chemiexcitation axis forms a lineage-specific redox circuit linking oxidative metabolism to mutation density, nitrosylation signaling, and immune evasion. Genome-wide mapping further indicates that chemiexcitation concentrates damage within open, transcriptionally active chromatin.
Critical Issues:
Key gaps remain in defining how pigment oxidation state, NOS flux, and subcellular organization coordinate chemiexcitation and nitrosylation in vivo, and how these processes reshape DNA repair and interferon programs across melanoma states. Parallels in neuromelanin, the retinal pigment epithelium, and mucosal pigment systems are provocative but require direct mechanistic validation.
Future Directions:
Targeting pigment chemistry itself, through NOS inhibition, denitrosylation, and triplet-state quenching, offers a compelling translational strategy to suppress dCPDs, rebalance redox signaling, and restore immune function. Coupling these interventions to quantitative biomarkers of pigment oxidation, nitrosylation networks, and chemiexcitation activity may enable patient stratification and rational therapeutic sequencing, transforming melanin from a risk modifier into an actionable redox interface. Antioxid. Redox Signal. 44, 618–635.
ChenX, ZouZ, WangQ, et al.Inhibition of NOS1 promotes the interferon response of melanoma cells. J Transl Med, 2022; 20(1):205.
8.
DE VriesTJ, FourkourA, WobbesT, et al.Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res, 1997; 57(15):3223–3229.
9.
DenatL, KadekaroAL, MarrotL, et al.Melanocytes as Instigators and Victims of Oxidative Stress. J Invest Dermatol, 2014; 134(6):1512–1518.
10.
DingZ, OgataD, RoszikJ, et al.iNOS Associates With Poor Survival in Melanoma: A Role for Nitric Oxide in the PI3K-AKT Pathway Stimulation and PTEN S-Nitrosylation. Front Oncol, 2021; 11:631766.
11.
D’ischiaM, WakamatsuK, CicoiraF, et al.Melanins and melanogenesis: From pigment cells to human health and technological applications. Pigment Cell Melanoma Res, 2015; 28(5):520–544.
12.
EkmekciogluS, GrimmEA, RoszikJ. Targeting iNOS to increase efficacy of immunotherapies. Hum Vaccin Immunother, 2017; 13(5):1105–1108.
13.
ElliottK, SinghVK, BostromM, et al.Base-resolution UV footprinting by sequencing reveals distinctive damage signatures for DNA-binding proteins. Nat Commun, 2023; 14(1):2701.
14.
FeckerLF, EberleJ, OrfanosCE, et al.Inducible nitric oxide synthase is expressed in normal human melanocytes but not in melanoma cells in response to tumor necrosis factor-α, interferon-γ, and lipopolysaccharide. J Invest Dermatol, 2002; 118(6):1019–1025.
15.
FernandoV, ZhengX, WaliaY, et al.S-Nitrosylation: An Emerging Paradigm of Redox Signaling. Antioxidants (Basel), 2019; 8(9):404.
16.
FosterMW, HessDT, StamlerJS. Protein S-nitrosylation in health and disease: A current perspective. Trends Mol Med, 2009; 15(9):391–404.
17.
FrigolaJ, SabarinathanR, Gonzalez-PerezA, et al.Variable interplay of UV-induced DNA damage and repair at transcription factor binding sites. Nucleic Acids Res, 2021; 49(2):891–901.
18.
GargSK, SunJ, KimY, et al.Dichotomous Nitric Oxide-Dependent Post-Translational Modifications of STAT1 Are Associated with Ipilimumab Benefits in Melanoma. Cancers (Basel), 2023; 15(6):1755.
19.
GoncalvesLCP, Angele-MartinezC, PremiS, et al.Chemiexcited Neurotransmitters and Hormones Create DNA Photoproducts in the Dark. ACS Chem Biol, 2023; 18(3):484–493.
GrimmEA, SikoraAG, EkmekciogluS. Molecular Pathways: Inflammation-Associated Nitric-Oxide Production as a Cancer-Supporting Redox Mechanism and a Potential Therapeutic Target. Clin Cancer Res, 2013; 19(20):5557–5563.
22.
HaqR, ShoagJ, Andreu-PerezP, et al.Oncogenic BRAF regulates oxidative metabolism via PGC1alpha and MITF. Cancer Cell, 2013; 23(3):302–315.
23.
HaydenMS, GhoshS. NF-kappaB in immunobiology. Cell Res, 2011; 21(2):223–244.
24.
HeN, ChenY, LewittPA, et al.Application of Neuromelanin MR Imaging in Parkinson Disease. J Magn Reson Imaging, 2023; 57(2):337–352.
25.
Hernansanz-AgustinP, Izquierdo-AlvarezA, Garcia-OrtizA, et al.Nitrosothiols in the immune system: Signaling and protection. Antioxid Redox Signal, 2013; 18(3):288–308.
26.
HuJC, AdarS, SelbyCP, et al.Genome-wide analysis of human global and transcription-coupled excision repair of UV damage at single-nucleotide resolution. Genes Dev, 2015; 29(9):948–960.
27.
HuJ, AdebaliO, AdarS, et al.Dynamic maps of UV damage formation and repair for the human genome. Proc Natl Acad Sci U S A, 2017; 114(26):6758–6763.
28.
HuJ, LiW, AdebaliO, et al.Genome-wide mapping of nucleotide excision repair with XR-seq. Nat Protoc, 2019; 14(1):248–282.
29.
ItoS, WakamatsuK, OzekiH. Chemical analysis of melanins and its application to the study of the regulation of melanogenesis. Pigment Cell Res, 2000; 13(Suppl 8):103–109.
30.
ItoT, KurataN, FukunagaY. Tissue-Resident macrophages in the stria vascularis. Front Neurol, 2022; 13:818395.
31.
JessenC, KreßJKC, BaluapuriA, et al.The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression. Oncogene, 2020; 39(44):6841–6855.
32.
JiangY, LiW, Lindsey-BoltzLA, et al.Super hotspots and super coldspots in the repair of UV-induced DNA damage in the human genome. J Biol Chem, 2021; 296:100581.
33.
JimenezJ, DubeyP, CarterB, et al.A metabolic perspective on nitric oxide function in melanoma. Biochim Biophys Acta Rev Cancer, 2024; 1879(1):189038.
34.
JourneF, Id BoufkerH, VAN KempenL, et al.TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome. Br J Cancer, 2011; 105(11):1726–1732.
35.
KaufmannM, HanZ. RPE melanin and its influence on the progression of AMD. Ageing Res Rev, 2024; 99:102358.
36.
LiM, LiuD, LeeD, et al.Targeted Alpha-Particle Radiotherapy and Immune Checkpoint Inhibitors Induces Cooperative Inhibition on Tumor Growth of Malignant Melanoma. Cancers (Basel), 2021; 13(15):3676.
37.
LiZ, LapennaKB, GehredND, et al.Dysregulated protein s-nitrosylation promotes nitrosative stress and disease progression in heart failure with preserved ejection fraction. Circ Res, 2025; 137(9):1185–1206.
38.
LiangF, WangM, LiJN, et al.The evolution of -nitrosylation detection methodology and the role of protein-nitrosylation in various cancers. Cancer Cell International, 2024; 24(1):408.
39.
MaX, WangS, WangS, et al.Biodistribution, radiation dosimetry, and clinical application of a melanin-targeted PET Probe, (18)F-P3BZA, in patients. J Nucl Med, 2019; 60(1):16–22.
40.
MaQ. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol, 2013; 53:401–426.
41.
ManaiF, SmedowskiA, KaarnirantaK, et al.Extracellular vesicles in degenerative retinal diseases: A new therapeutic paradigm. J Control Release, 2024; 365:448–468.
42.
Mandelcorn-MonsonRL, ShearNH, YauE, et al.Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients. J Invest Dermatol, 2003; 121(3):550–556.
43.
MassiD, DE NisiMC, FranchiA, et al.Inducible nitric oxide synthase expression in melanoma: Implications in lymphangiogenesis. Mod Pathol, 2009; 22(1):21–30.
44.
MauryaM, BoraK, BlomfieldAK, et al.Oxidative stress in retinal pigment epithelium degeneration: From pathogenesis to therapeutic targets in dry age-related macular degeneration. Neural Regen Res, 2023; 18(10):2173–2181.
45.
MoX, KazmiHR, Preston-AlpS, et al.Interferon-gamma induces melanogenesis via post-translational regulation of tyrosinase. Pigment Cell Melanoma Res, 2022; 35(3):342–355.
46.
MolonB, UgelS, DEL PozzoF, et al.Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. J Exp Med, 2011; 208(10):1949–1962.
47.
MonteiroHP, CostaPE, ReisAK, et al.Nitric oxide: Protein tyrosine phosphorylation and protein S-nitrosylation in cancer. Biomed J, 2015; 38(5):380–388.
48.
Moreno-GarciaA, KunA, CaleroM, et al.The neuromelanin paradox and its dual role in oxidative stress and neurodegeneration. Antioxidants (Basel), 2021; 10(1):124.
49.
MouretS, BaudouinC, CharveronM, et al.Cyclobutane pyrimidine dimers are predominant DNA lesions in whole human skin exposed to UVA radiation. Proc Natl Acad Sci U S A, 2006; 103(37):13765–13770.
50.
NapolitanoA, PanzellaL, MonfrecolaG, et al.Pheomelanin-induced oxidative stress: Bright and dark chemistry bridging red hair phenotype and melanoma. Pigment Cell Melanoma Res, 2014; 27(5):721–733.
51.
NastiTH, TimaresL. MC1R, eumelanin and pheomelanin: Their role in determining the susceptibility to skin cancer. Photochem Photobiol, 2015; 91(1):188–200.
52.
OgawaT, IshitsukaY. NRF2 in the epidermal pigmentary system. Biomolecules, 2022; 13(1):20.
PoetschAR, BoultonSJ, LuscombeNM. Genomic landscape of oxidative DNA damage and repair reveals regioselective protection from mutagenesis. Genome Biol, 2018; 19(1):215.
56.
PospisilP, PaculovaV, PrasadA, et al.Chemiexcitation in Ex Vivo Porcine Skin Model. Pigment Cell Melanoma Res, 2025; 38(6):e70060.
57.
PremiS, WallischS, ManoCM, et al.Photochemistry. Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposure. Science, 2015; 347(6224):842–847.
58.
PremiS, BrashDE. Chemical excitation of electrons: A dark path to melanoma. DNA Repair (Amst), 2016; 44:169–177.
59.
PremiS, HanL, MehtaS, et al.Genomic sites hypersensitive to ultraviolet radiation. Proc Natl Acad Sci U S A, 2019; 116(48):24196–24205.
60.
ProsperiMT, GiordanoC, Gomez-DuroM, et al.Extracellular vesicles released by keratinocytes regulate melanosome maturation, melanocyte dendricity, and pigment transfer. Proc Natl Acad Sci USA, 2024; 121(16):e2321323121.
61.
ReszkaKJ, MatuszakZ, ChignellCF. Lactoperoxidase-catalyzed oxidation of melanin by reactive nitrogen species derived from nitrite (NO2-): An EPR study. Free Radic Biol Med, 1998; 25(2):208–216.
62.
RizzaS, FilomeniG. Role, Targets and Regulation of (de)nitrosylation in Malignancy. Front Oncol, 2018; 8:334.
63.
Romero-GrailletC, AberdamE, ClementM, et al.Nitric oxide produced by ultraviolet-irradiated keratinocytes stimulates melanogenesis. J Clin Invest, 1997; 99(4):635–642.
64.
RosenbergSA. A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity, 1999; 10(3):281–287.
65.
SabarinathanR, MularoniL, Deu-PonsJ, et al.Nucleotide excision repair is impaired by binding of transcription factors to DNA. Nature, 2016; 532(7598):264–267.
66.
SasakiM, HorikoshiT, UchiwaH, et al.Up-regulation of gene by nitric oxide in human melanocytes. Pigment Cell Res, 2000; 13(4):248–252.
67.
SharmaV, FernandoV, LetsonJ, et al.S-Nitrosylation in Tumor Microenvironment. Int J Mol Sci, 2021; 22(9):4600.
68.
ShinJM, KimMY, SohnKC, et al.Nrf2 negatively regulates melanogenesis by modulating PI3K/Akt signaling. PLoS One, 2014; 9(4):e96035.
69.
SripathiSR, HeW, UmJY, et al.Nitric oxide leads to cytoskeletal reorganization in the retinal pigment epithelium under oxidative stress. Adv Biosci Biotechnol, 2012; 3:1167–1178.
70.
SrivastavaJ, YadavVK, JimenezRV, et al.Blocking Nitrosylation Induces Immunogenic Cell Death by Sensitizing NRAS-Mutant Melanoma to MEK Inhibitors. Cancer Res, 2025; 85(12):2268–2287.
71.
SturmRA, SmitDJ, DuffyDL, et al.Uncovering the molecular mechanisms of amelanotic/hypopigmented primary cutaneous melanoma. Br J Dermatol, 2024; 192(1):55–62.
72.
TaneseK, GrimmEA, EkmekciogluS. The role of melanoma tumor-derived nitric oxide in the tumor inflammatory microenvironment: Its impact on the chemokine expression profile, including suppression of CXCL10. Int J Cancer, 2012; 131(4):891–901.
73.
TaylorAW, HsuS, NgTF. The Role of Retinal Pigment Epithelial Cells in Regulation of Macrophages/Microglial Cells in Retinal Immunobiology. Front Immunol, 2021; 12:724601.
74.
TcyganovEN, SansevieroE, MarvelD, et al.Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapy. Cancer Cell, 2022; 40(10):1173–1189 e6.
75.
TeleanuDM, NiculescuAG, LunguII, et al.An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases. Int J Mol Sci, 2022; 23(11):5938.
76.
TimminsGS, DOS SantosRE, WhitwoodAC, et al.Lipid peroxidation-dependent chemiluminescence from the cyclization of alkylperoxyl radicals to dioxetane radical intermediates. Chem Res Toxicol, 1997; 10(10):1090–1096.
77.
TsatmaliM, GrahamA, SzatkowskiD, et al.alpha-melanocyte-stimulating hormone modulates nitric oxide production in melanocytes. J Invest Dermatol, 2000; 114(3):520–526.
78.
TsoiJ, RobertL, ParaisoK, et al.Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress. Cancer Cell, 2018; 33(5):890–904.e5.
79.
VicoLD, LiuYJ, KroghJW, et al.Chemiluminescence of 1,2-dioxetane. Reaction mechanism uncovered. J Phys Chem A, 2007; 111(32):8013–8019.
80.
WangZ, DillonJ, GaillardER. Antioxidant properties of melanin in retinal pigment epithelial cells. Photochem Photobiol, 2006; 82(2):474–479.
81.
WellerR. Nitric oxide, skin growth and differentiation: More questions than answers? Clin Exp Dermatol, 1999; 24(5):388–391.
82.
WillemsenM, BulgarelliJ, ChauhanSK, et al.Changes in AXL and/or MITF melanoma subpopulations in patients receiving immunotherapy. Immunooncol Technol, 2024; 24:101009.
83.
WilmsH, RosenstielP, SieversJ, et al.Activation of microglia by human neuromelanin is NF-κB-dependent and involves p38 mitogen-activated protein kinase: Implications for Parkinson’s disease. Faseb J, 2003; 17(3):500–502.
84.
WondrakG, PierT, TresslR. Light from Maillard reaction: Photon counting, emission spectrum, photography and visual perception. J Biolumin Chemilumin, 1995; 10(5):277–284.
85.
XuX, YuanL, GaiY, et al.Targeted radiotherapy of pigmented melanoma with (131)I-5-IPN. J Exp Clin Cancer Res, 2018; 37(1):306.
86.
YadavVK, SrivastavaJ, VenkatachalamA, et al.Melanin-Driven Delayed CPD Formation Is Independent of Melanin Biosynthesis Pathway. J Invest Dermatol, 2025:S0022.
87.
YangY, ZhouM, ZhaoS, et al.First-in-human PET imaging and evaluation of melanin-targeted [(18)F]DMPY2 in malignant melanoma patients. Theranostics, 2025; 15(13):6100–6110.
88.
YarlagaddaK, HassaniJ, FooteIP, et al.The role of nitric oxide in melanoma. Biochim Biophys Acta Rev Cancer, 2017; 1868(2):500–509.
89.
ZhangW, PhillipsK, WielgusAR, et al.Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: Implications for progression of Parkinson’s disease. Neurotox Res, 2011; 19(1):63–72.
90.
ZuccaFA, BassoE, CupaioliFA, et al.Neuromelanin of the human substantia nigra: An update. Neurotox Res, 2014; 25(1):13–23.
91.
ZuccaFA, CapucciatiA, BelleiC, et al.Neuromelanins in brain aging and Parkinson’s disease: Synthesis, structure, neuroinflammatory, and neurodegenerative role. IUBMB Life, 2023; 75(1):55–65.
